DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC).

DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). Acta Oncol. 2019 Jul 08;:1-4 Authors: Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J PMID: 31282236 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31282236?dopt=Abstract

Source: Acta Oncologica - July 7, 2019 Category: Cancer & Oncology Authors: Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J Tags: Acta Oncol Source Type: research